422 related articles for article (PubMed ID: 8636304)
1. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
[TBL] [Abstract][Full Text] [Related]
4. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.
Zhou Y; Sun H; Danila DC; Johnson SR; Sigai DP; Zhang X; Klibanski A
Mol Endocrinol; 2000 Dec; 14(12):2066-75. PubMed ID: 11117535
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.
Danila DC; Zhang X; Zhou Y; Haidar JN; Klibanski A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4741-6. PubMed ID: 12364468
[TBL] [Abstract][Full Text] [Related]
6. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
7. Identification of a functional binding site for activin on the type I receptor ALK4.
Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
[TBL] [Abstract][Full Text] [Related]
8. Bovine activin receptor type IIB messenger ribonucleic acid displays alternative splicing involving a sequence homologous to Src-homology 3 domain binding sites.
Ethier JF; Lussier JG; Silversides DW
Endocrinology; 1997 Jun; 138(6):2425-34. PubMed ID: 9165032
[TBL] [Abstract][Full Text] [Related]
9. Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?
Schulte KM; Jonas C; Krebs R; Röher HD
Horm Metab Res; 2000 Oct; 32(10):390-400. PubMed ID: 11069203
[TBL] [Abstract][Full Text] [Related]
10. Expression of inhibin alpha, and beta A subunit and activin type II receptor mRNAs in various human pituitary adenomas.
Demura R; Tajima S; Suzuki T; Yajima R; Odagiri E; Suda T; Tozawa F; Demura H; Kato H; Uchiyama T
Endocr J; 1995 Feb; 42(1):95-100. PubMed ID: 7599706
[TBL] [Abstract][Full Text] [Related]
11. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
Abbass SA; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
[TBL] [Abstract][Full Text] [Related]
13. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
14. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
[TBL] [Abstract][Full Text] [Related]
15. Ovarian regulation of pituitary inhibin subunit and activin receptor type II gene expression: evidence for a nonsteroidal inhibitory substance.
Dalkin AC; Gilrain JT; Marshall JC
Endocrinology; 1994 Sep; 135(3):944-9. PubMed ID: 8070390
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGF-beta superfamily receptors in dental pulp.
Toyono T; Nakashima M; Kuhara S; Akamine A
J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
Fujiwara K; Ikeda H; Yoshimoto T
Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536
[TBL] [Abstract][Full Text] [Related]
19. Activin effects on neoplastic proliferation of human pituitary tumors.
Danila DC; Inder WJ; Zhang X; Alexander JM; Swearingen B; Hedley-Whyte ET; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1009-15. PubMed ID: 10720031
[TBL] [Abstract][Full Text] [Related]
20. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]